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Introduction
Mitochondria are essential organelles whose structure and func-
tion adapt to different cellular conditions through continuous 
fusion and fi  ssion events (Okamoto and Shaw, 2005). Mitochon-
drial dynamics exert essential physiological and developmental 
roles, regulate apoptotic processes, and affect energy production 
within mitochondria (Chen and Chan, 2005). Two neuropathies, 
Charcot-Marie-Tooth type 2A and autosomal dominant optic at-
rophy, are caused by mutations in essential fusion components, 
namely, mitofusin 2 or OPA1 (Chen and Chan, 2005). Although 
several components involved in fusion have been identifi  ed, 
many of them in yeast, molecular mechanisms underlying mito-
chondrial fusion events are poorly understood. A central role 
has been assigned to yeast Fzo1 in the outer membrane of mito-
chondria (or to its mammalian homologues mitofusin 1 and 2) 
as part of a fusion complex that also contains Ugo1 and Mgm1 
in yeast (Meeusen and Nunnari, 2005).
Less clear is the role of the F-box protein Mdm30, whose 
loss leads to the accumulation of aggregated and fragmented 
mitochondria (Fritz et al., 2003). Among the 21 annotated 
 proteins  of  Saccharomyces cerevisiae with an F-box motif 
(Willems et al., 2004), some assemble in Skp1–Cdc53–F-box 
(SCF) E3 ubiquitin ligase complexes, which mediate protea-
somal proteolysis of specifi  c substrates (Petroski and Deshaies, 
2005). Indeed, Mdm30 has been linked to the turnover of the 
transcription factor Gal4 in the nucleus (Muratani et al., 2005). 
Mdm30 was not only localized to the cytosolic fraction but also 
found in association with mitochondria (Fritz et al., 2003). 
Therefore, in analogy to the degradation of resident ER  proteins, 
Mdm30 may affect mitochondrial dynamics by coupling the 
mitochondrial fusion machinery to the ubiquitin–proteasome 
system (UPS) in the cytosol. Consistently, accumulation of 
Fzo1 has been observed in cells lacking Mdm30 (Fritz et al., 
2003). However, it remained unclear whether this indeed 
 refl  ects Mdm30-dependent proteolysis of Fzo1 and whether the 
UPS is involved. Notably, 26S proteasomes have been linked 
to the degradation of Fzo1 in α-factor–arrested yeast cells 
(Neutzner and Youle, 2005). However, degradation does not 
depend on Mdm30 under these conditions (Neutzner and Youle, 
2005). Moreover, the involvement of 26S proteasomes  remained 
controversial, as only proteasome inhibitors have been used, 
which are known to be effective only in yeast cells with 
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itochondrial morphology depends on   balanced 
fusion and ﬁ  ssion events. A central component 
of the mitochondrial fusion apparatus is the 
conserved GTPase Fzo1 in the outer membrane of mito-
chondria. Mdm30, an F-box protein required for 
  mitochondrial fusion in vegetatively growing cells, affects 
the cellular Fzo1 concentration in an unknown manner. 
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control of Fzo1 levels, which is ensured by Fzo1 turnover. 
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function of an F-box protein. This contrasts to the   ubiquitin- 
and proteasome-dependent turnover of Fzo1 in α-factor–
arrested yeast cells. Our results therefore reveal not only a 
critical role of Fzo1 degradation for mitochondrial fusion 
in vegetatively growing cells but also the existence of two 
distinct proteolytic pathways for the turnover of mitochon-
drial outer membrane proteins.
Correspondence to Thomas Langer: Thomas.Langer@uni-koeln.de
Abbreviations used in this paper: CCCP, carbonylcyanide m-chlorophenylhydra-
zone; mtGFP, mitochondria-targeted GFP; SCF, Skp1–Cdc53–F-box; UPS, 
  ubiquitin–proteasome system.JCB • VOLUME 173 • NUMBER 5 • 2006  646
 increased membrane permeability or lacking drug-effl  ux pumps 
(Lee and Goldberg, 1996).
We have analyzed the role of Mdm30 for the regulation of 
mitochondrial dynamics and demonstrate for the fi  rst  time 
Mdm30-dependent proteolysis of Fzo1 in vegetatively growing 
yeast cells. Mdm30 is part of a novel proteolytic pathway that 
does not involve SCF complexes and 26S proteasomes and thus 
is strikingly different to the proteasomal degradation of Fzo1 in 
α-factor–arrested yeast cells.
Results and discussion
Mdm30-dependent and -independent 
degradation of Fzo1
The accumulation of Fzo1 in ∆mdm30 cells suggests that the 
F-box protein Mdm30 is involved in the degradation of Fzo1 
(Fig. 1 A; Fritz et al., 2003). We therefore assessed the stability 
of Fzo1 in wild-type and ∆mdm30 cells after inhibition of 
  protein synthesis with cycloheximide. This analysis revealed 
that Fzo1 is constitutively degraded in wild-type cells, whereas 
it remained stable in the absence of Mdm30 (Fig. 1 A). Similar 
experiments were performed in yeast cells in the exponential or 
post–diauxic-shift phase, but a signifi  cant dependence of Fzo1 
stability on the growth phase was not observed (Fig. 1 A). 
To distinguish between complete Fzo1 turnover and processing, 
we followed Fzo1 degradation using antibodies directed against 
either the NH2-terminal GTPase domain or a peptide located 
at the COOH-terminal segment of Fzo1. Moreover, the stability 
of an Fzo1 variant carrying an NH2-terminal HA tag was 
  examined. As no proteolytic fragments of Fzo1 were detected, 
we conclude that Fzo1 is completely degraded in an Mdm30-
 dependent  manner.
Mdm30 might affect the localization and/or complex as-
sembly of Fzo1 and thereby affect Fzo1 stability and mitochon-
drial fusion. Therefore, mitochondrial and postmitochondrial 
supernatant fractions of wild-type and ∆mdm30 cells were ana-
lyzed for the presence of Fzo1 (Fig. 1 B). Regardless of the 
presence of Mdm30, Fzo1 was recovered from the mitochon-
drial fraction, which also contained the mitochondrial outer 
membrane protein Tom40 but was devoid of the soluble cyto-
solic protein Tpi1 (Fig. 1 B). Fzo1 assembles into an 850-kD 
complex in wild-type cells (Rapaport et al., 1998) and was 
found to be present in a complex of the same size in ∆mdm30 
cells (Fig. 1 C). Thus, Mdm30 does not affect the assembly of 
Fzo1 in the outer membrane of mitochondria.
Fzo1 was recently reported to be degraded upon mating 
factor–induced cell cycle arrest (Neutzner and Youle, 2005; Fig. 
1 D). Intriguingly, under these conditions, proteolysis occurs 
independent of Mdm30 (Neutzner and Youle, 2005; Fig. 1 D) or 
any other nonessential yeast gene encoding an F-box protein 
(unpublished data). We therefore conclude that Fzo1 is degraded 
along two physiologically and mechanistically distinct path-
ways, one prevalent in vegetatively growing cells and the other 
in α-factor–arrested cells.
Mdm30 binds to Fzo1 and mediates 
proteolysis in an F-box–dependent manner
To assess the requirement of the Mdm30 F-box motif for Fzo1 
degradation, four conserved amino acid residues within the motif 
were replaced, namely, L19P, P20A, E22Q, and I23A (Fig. 2 A). 
In a second construct, the entire F-box was deleted (amino acids 
1–58; Fig. 2 A, ∆F-box). Wild-type or mutant forms of Mdm30 
were found in equal association with mitochondria upon subcel-
lular fractionation (unpublished data). After expression in wild-
type and ∆mdm30 strains, the steady-state level of Fzo1 was 
monitored by immunoblotting. In wild-type cells, the steady-state 
concentration of Fzo1 was unaffected by the presence of the mu-
tant Mdm30 forms (Fig. 2 B). In ∆mdm30 cells, however, only wild-
type Mdm30 but not Mdm30 variants with a defective F-box 
were able to restore degradation and low Fzo1 steady-state con-
centrations (Fig. 2 B). These results demonstrate that proteolysis 
of Fzo1 depends on the integrity of the Mdm30 F-box.
Figure 1.  Fzo1 stability is controlled by two independent pro-
teolytic pathways. (A, top) The stability of Fzo1 in exponentially 
growing (exp) or post–diauxic-shift cultures (PDS) after adding 
cycloheximide (CHX) was monitored by SDS-PAGE and immuno-
blotting. (bottom) A quantiﬁ  cation including standard deviation 
of three independent experiments. (B) Cellular subfractionation. 
  Exponentially growing wild-type (wt) and ∆mdm30 cells were 
split by differential centrifugation into a mitochondrial (pellet) and 
a cytosolic (sup) fraction as described previously (Rapaport et al., 
1998). The fractions were analyzed by SDS-PAGE and immuno-
blotting for the presence of Fzo1. The mitochondrial outer mem-
brane protein Tom40 and the cytosolic protein Tpi1 were used as 
marker proteins to validate the fractionation. (C) Complex forma-
tion of Fzo1 in the mitochondrial outer membrane. Mitochondrial 
membranes of wild-type and ∆mdm30 cells were solubilized 
in Triton X-100 and fractionated by Superose 6 gel ﬁ  ltration 
chromatography. Eluate fractions were analyzed by immunoblotting 
using Fzo1-speciﬁ  c antibodies. (D) Fzo1 degradation upon α-factor–
induced cell cycle arrest. Fzo1 stability in cell cycle–arrested wild-
type and ∆mdm30 cells was analyzed as in A. The position of 
standard molecular mass markers during electrophoresis corre-
sponding to 116, 43, and 27 kD are indicated by the small bars 
in panels showing Fzo1, Tom40, or Tpi1, respectively.MDM30 REGULATES FZO1 TURNOVER • ESCOBAR-HENRIQUES ET AL. 647
To examine whether Mdm30 interacts directly with Fzo1, 
we performed coimmunoprecipitation experiments using Fzo1-
specifi  c antibodies in cells expressing Mdm30 or F-box variants 
thereof. Mdm30 was precipitated with Fzo1-specifi  c antibodies, 
demonstrating complex formation of both proteins in wild-type 
cells (Fig. 2 C). Thus, in agreement with studies on other F-box 
proteins (Skowyra et al., 1997), Fzo1 recognition by Mdm30 
does not depend on its F-box (Fig. 2 C). It should be noted that 
after solubization of mitochondrial membranes with digitonin, 
Mdm30 or mutant variants did not coelute with Fzo1 upon siz-
ing chromatography, indicating a rather dynamic interaction 
(unpublished data).
Mdm30-mediated Fzo1 turnover 
is independent of the SCF complex 
or of ubiquitylation
Mdm30 was found associated with both Skp1 and Cdc53 in high 
throughput protein–protein interaction studies (Uetz et al., 2000) 
and in vitro (Kus et al., 2004). Its requirement for Fzo1 proteoly-
sis therefore suggests that degradation occurs through ubiquity-
lation by SCF complexes (Petroski and Deshaies, 2005). Protein 
shut-off experiments were performed in cells defi  cient for core 
components of SCF complexes (skp1-11, skp1-12, and cdc53-1) 
or for the E2 enzyme Cdc34 (cdc34-2). Fzo1 was degraded in 
these SCF-defi  cient cells with kinetics similar to those of wild-
type cells (Fig. 3 A). This was in contrast to Grr1, a known sub-
strate of the SCF complex (Galan and Peter, 1999), which stably 
accumulated in these mutants (Fig. 3 B). We also analyzed the 
stability of Fzo1 in cells that allow tetracycline-sensitive expres-
sion of the essential genes CDC53 and CDC34 (Mnaimneh et al., 
2004) but did not observe a stabilization of Fzo1 upon repression 
of  CDC53 or CDC34 (unpublished data). Thus, Mdm30-
  dependent proteolysis of Fzo1 does not require SCF ubiquitin 
 ligase  complexes.  These  fi  ndings are reminiscent of the F-box 
proteins Ctf13 and Rcy1, which do not assemble in SCF  complexes 
(Russell et al., 1999; Galan et al., 2001), and substantiate that 
F-box proteins may exert cellular functions other than ubiquitin-
dependent protein degradation. It should be emphasized, however, 
that Mdm30 could mediate the degradation of other substrate pro-
teins by interaction with SCF complexes. This hypothesis is sup-
ported by the recently observed Mdm30-dependent ubiquitylation 
of Gal4 in the nucleus (Muratani et al., 2005).
To directly examine a possible ubiquitylation of Fzo1 by 
other E3 ubiquitin ligases, cellular ubiquitin pools were limited 
either by using a mutant E1 enzyme (uba1
ts) or through the 
overexpression of mutant ubiquitin forms, unable to form ubiq-
uitin chains (K29R, K48R, K63R, or RRR). Neither approach 
caused a stabilization of Fzo1 (Fig. 3 C). We conclude that 
Mdm30-dependent constitutive Fzo1 degradation is indepen-
dent of SCF and ubiquitin.
We also examined the role of ubiquitylation for Fzo1 pro-
teolysis upon mating factor–induced cell cycle arrest in uba1
ts 
Figure 2.  The constitutive Fzo1 turnover depends on the F-box motif of its in-
teracting partner, Mdm30. (A) Schematic representation of Mdm30 variants. 
The Mdm30 derivative F-box* was obtained, replacing amino acid residues 
19, 20, 22, and 23 within consensus residues of the F-box motif of Mdm30 
as shown. The variant ∆F-box was generated by deleting amino acid residues 
1–58 of Mdm30. (B) Mitochondrial extracts of wild-type (wt) and ∆mdm30 
strains expressing Mdm30 variants or transformed with the vector control 
were analyzed by immunoblotting using Fzo1-speciﬁ   c and, as a loading 
control, Tom40-speciﬁ  c antibodies. (C) Mitochondria derived from wild-type 
cells expressing several Mdm30 variants harboring an NH2-terminal Flag epi-
tope or cells transformed with the vector control were solubilized in digitonin 
and subjected to immunoprecipitation using Fzo1-speciﬁ  c antibodies. Total 
extracts (input; 5%) and immunoprecipitates (IP; 100%) were analyzed by im-
munoblotting with antibodies directed against the Flag epitope of the Mdm30 
proteins. The position of standard molecular mass markers during electropho-
resis corresponding to 116, 43, and 66 kD are indicated by the small bars in 
panels showing Fzo1, Tom40, or Mdm30, respectively.
Figure 3.  Differential requirement of ubiquitylation for constitu-
tive and induced Fzo1 degradation. (A–C) The stability of Fzo1 
and Grr1-myc was analyzed after inhibition of cytosolic protein 
synthesis with cycloheximide (CHX) in vegetatively growing wild-
type (wt), ∆mdm30, cdc34-2, cdc53-1, skp1-11, skp1-12, and 
uba1
ts cells at 37°C, as described in Fig. 1 A. (D) Proteolysis of 
Fzo1 in the presence of α-factor was monitored at 37°C in wild-
type and uba1
ts cells. The position of standard molecular mass 
markers during electrophoresis corresponding to 158 and 116 kD 
are indicated by the small bars in panels showing Grr1 or 
Fzo1, respectively.JCB • VOLUME 173 • NUMBER 5 • 2006  648
cells and found it to be impaired (Fig. 3 D). Thus, in striking 
contrast to its constitutive and Mdm30-dependent degradation, 
the proteolytic breakdown of Fzo1 in arrested cells is ubiqui-
tin dependent (Fig. 3 D).
Proteasome independence and ATP 
dependence of Fzo1 degradation
We next examined the stability of Fzo1 in yeast cells with defi  -
cient proteasomal activity. Proteolysis of Fzo1 was not impaired 
in pre1-1 or cim5-1 cells carrying mutations in a proteolytic 
subunit of the 20S core particle or in an ATPase subunit of the 
19S regulatory complex, respectively (Fig. 4 A). Similarly, de-
letion of the proteasomal assembly factor Ump1 did not inter-
fere with the proteolytic breakdown of Fzo1 in vegetatively 
growing cells (Fig. 4 A). This is in contrast to Fzo1 proteolysis 
in cells arrested in the presence of mating factor (Fig. 4 B). In 
agreement with previous inhibitor studies (Neutzner and Youle, 
2005), Fzo1 remained stable after treating pre1-1 or cim5-1 
cells with α-factor (Fig. 4 B). We conclude that the constitutive 
Mdm30-dependent turnover of Fzo1 occurs independently of 
the 26S proteasome, whereas degradation of Fzo1 upon α- factor 
arrest involves ubiquitylation and 26S proteasomes.
To further characterize the Mdm30-mediated Fzo1 pro-
teolysis, we examined a potential ATP dependence of this pro-
teolytic pathway. Two chemical inhibitors of ATP production in 
mitochondria were used: NaN3, an inhibitor of the   cytochrome c
oxidase, and carbonylcyanide m-chlorophenylhydrazone (CCCP), 
an uncoupler dissipating the membrane potential across the 
  mitochondrial inner membrane. Both treatments completely 
blocked degradation of Fzo1, which appears to be ATP 
 dependent  (Fig. 4 C).
We therefore analyzed the stability of Fzo1 in mitochon-
dria lacking the ATP-dependent i-AAA protease subunit Yme1, 
which is active in the intermembrane space of mitochondria 
(Leonhard et al., 1996), but did not observe any effect on Fzo1 
degradation (Fig. 4 A). Moreover, we examined the involve-
ment of vacuolar degradation, which is responsible for the gen-
eral removal of mitochondrial proteins under rapamycin-induced 
autophagic conditions (Kissova et al., 2004). However, Fzo1 
was not stabilized in pep4 cells lacking active vacuolar pepti-
dases (Fig. 4 A). We conclude that Fzo1 is constitutively de-
graded by a yet unknown proteolytic system whose activity is 
apparently ATP dependent.
Mdm30 controls mitochondrial fusion 
exclusively through Fzo1 proteolysis
Deletion of MDM30 impairs mitochondrial fusion and results 
in the formation of fragmented mitochondria accompanied 
by the accumulation of Fzo1 (Fig. 5 A; Fritz et al., 2003). 
To   examine whether Fzo1 accumulation in ∆mdm30 cells is 
a general consequence of impaired mitochondrial fusion, the 
steady-state concentrations of Fzo1 were determined in ∆ugo1, 
∆mgm1, and ∆pcp1 mutant cells. Fzo1 did not accumulate in 
either of these mutant cells, demonstrating that there is no 
  direct link between the cellular level of Fzo1 and ongoing 
  mitochondrial fusion (Fig. 5 B). To further substantiate the 
specifi  c effect of Mdm30 on Fzo1 stability and mitochondrial 
fusion, we analyzed the   effect on the steady-state level of Fzo1 
of the 131 nonessential deletion strains and in the 16 tet-off 
essential genes known to have fragmented mitochondria (Dimmer 
et al., 2002; Altmann and Westermann, 2005). However, apart 
from ∆mdm30 cells, we did not observe altered Fzo1 levels 
(unpublished data). It therefore seems likely that Mdm30 af-
fects mitochondrial dynamics by specifi  cally regulating the 
stability of Fzo1.
To substantiate the specifi  c effect of Mdm30 on Fzo1, we 
assessed mitochondrial morphology upon overexpression of 
Fzo1 in wild-type cells. Strikingly, mitochondria in cells over-
expressing Fzo1 in the presence of an MDM30 wild-type allele 
resembled the fragmented mitochondria seen in ∆mdm30 cells 
(Fig. 5 A). In agreement with this observation, proteolysis of 
Fzo1 was only observed when Fzo1 was expressed from a cen-
tromeric low-copy plasmid but not when expressed from a mul-
ticopy plasmid (Fig. 5 C). These fi  ndings were further supported 
by modulating Fzo1 expression in wild-type and ∆mdm30 cells 
using the inducible GAL1 promoter. Growing yeast cells in the 
presence of glucose, raffi  nose, or galactose results in repres-
sion, nonrepression, or induction of Fzo1 synthesis. Impor-
tantly, tubular mitochondria were observed in ∆mdm30 cells 
grown under nonrepressed conditions in the presence of raffi  -
nose, i.e., at intermediate expression levels of Fzo1 (Fig. 5 D 
and Table I). This confi  rms that mitochondrial morphology can 
be modulated by changing Fzo1 expression levels. Thus, mito-
chondrial fusion requires a tight control of the steady-state con-
centration of Fzo1. We conclude that lowering Fzo1 protein 
levels allows bypassing of Mdm30. Therefore, Mdm30 pro-
motes mitochondrial fusion exclusively by controlling the 
steady-state level of Fzo1.
Overexpressing Fzo1 in wild-type cells prevents its degra-
dation, suggesting that Mdm30 could be the limiting factor. 
Figure 4.  Fzo1 degradation is mediated by a novel proteolytic system. 
(A) The stability of Fzo1 was monitored in wild-type (wt), ∆mdm30, pre1-1, 
cim5-1, ∆ump1, ∆yme1, and ∆pep4 cells after addition of cycloheximide 
(CHX) as in Fig. 1 A. (B) Fzo1 stability upon α-factor–induced cell cycle 
  arrest was examined in wild-type, pre1-1, and cim5-1 cells, which also 
lacked BAR1. (C) Exponentially growing wild-type cells were treated with 
cycloheximide (CHX) and additionally with sodium azide (NaN3) or CCCP 
as indicated. The stability of Fzo1 was determined as in Fig. 1 A. The posi-
tion of the standard molecular mass marker during electrophoresis corre-
sponding to 116 kD is indicated by the small bars.MDM30 REGULATES FZO1 TURNOVER • ESCOBAR-HENRIQUES ET AL. 649
Therefore, Mdm30 was overexpressed in cells containing a 
 galactose-inducible  FZO1 allele. Surprisingly, we found that the 
simultaneous overexpression of Fzo1 and Mdm30 is deleterious 
for cellular growth and leads to abnormal cellular and mito-
chondrial morphologies (Fig. 5 E). It is therefore conceivable 
that the Fzo1–Mdm30 complex sequesters an as-yet-unknown 
factor that is essential for growth.
Conclusions
Our experiments demonstrate a crucial role of Fzo1 proteolysis 
for the maintenance of mitochondrial morphology. The stability 
of Fzo1 is controlled by a novel, apparently ATP-dependent 
proteolytic system. This system involves the F-box protein 
Mdm30 but not ubiquitylation and SCF complexes, opening 
new perspectives for cellular activities of F-box proteins. Our 
results also demonstrate that proteins in the outer membrane of 
mitochondria can be degraded in at least two ways, only one of 
which is dependent on the UPS. At the same time, they suggest 
a mechanism that regulates organellar morphology by the use of 
two different proteolytic systems during different physiological 
states of a eukaryotic cell.
Materials and methods
Yeast strains and growth media
Yeast strains were grown according to standard procedures on complete 
or synthetic media supplemented with 2% (wt/vol) glucose or, when indi-
cated, 2% (wt/vol) galactose or rafﬁ  nose and 0.02% (wt/vol) glucose. 
100 μg/ml cycloheximide, 10 μM α-factor (or 0.1 μM in the case of ∆bar1 
cells), 2 mM NaN3, or 1 mM CCCP was added when indicated. The cell 
cycle arrest in the presence of α-factor was veriﬁ  ed microscopically.
Yeast strains used were derivatives of W303 and BY4741. The 
strains ∆mdm30, ∆fzo1, ∆ugo1, ∆pcp1, or ∆mgm1 and the isogenic wild-
type strain BY4741 were obtained from Euroscarf. For expression of Fzo1 
in wild-type and ∆mdm30 cells under the control of the GAL1 promoter, 
previously described strains were used (Fritz et al., 2003). MDM30 and 
PEP4 were deleted by PCR-based homologous recombination in W303. 
Figure 5.  Control of mitochondrial fusion by Mdm30-
  dependent proteolysis of Fzo1. (A) Cellular (Nomarski) and 
mitochondrial (GFP) morphology was visualized by ﬂ  uorescence 
microscopy after expressing mtGFP in wild-type (wt), ∆fzo1, 
and ∆mdm30 cells or in wild-type cells expressing Fzo1 from 
a multicopy plasmid under the control of the CUP1 promoter 
in the presence of added copper (50 μM; wt + Fzo12μ). 
(B) Steady-state concentrations of Fzo1 in extracts of the indi-
cated strains were analyzed by immunoblotting using Fzo1-
speciﬁ  c and, as a loading control, Tom40-speciﬁ  c antibodies. 
(C) Stability of Fzo1 present at different levels in wild-type and 
∆mdm30 cells. Protein synthesis shut-off experiments were 
performed as in Fig. 1 A using exponentially growing wild-
type or ∆mdm30 cells expressing HA-Fzo1 from either a cen-
tromeric (cen) or a multicopy (2μ) plasmid under the control 
of the endogenous FZO1 promoter. (D) Wild-type and 
∆mdm30 cells expressing mtGFP and harboring a chromo-
somal integration of the GAL1 promoter upstream of the 
FZO1 coding region were grown on glucose-, rafﬁ  nose-, or 
galactose-containing medium. Cellular (Nomarski) and mito-
chondrial (GFP) morphology was visualized after expression 
of mtGFP by ﬂ  uorescence microscopy. (E) Wild-type cells ex-
pressing mtGFP and harboring a chromosomal integration of 
the  GAL1 promoter upstream of the FZO1 coding region 
were grown on glucose- or galactose-containing medium. 
Cells were expressing MDM30 from a multicopy plasmid 
  under the control of the CUP1 promoter when indicated. 
  Cellular (Nomarski) and mitochondrial (GFP) morphology 
was visualized by ﬂ  uorescence microscopy. The position of 
standard molecular mass markers during electrophoresis corre-
sponding to 116 and 43 kD are indicated by the small bars 
in panels showing Fzo1 or Tom40, respectively. Bars, 5 μm.
Table I. Mitochondrial phenotypes upon different Fzo1 expression levels
Mitochondrial morphology (percentage of cells)
Strain/media Fragmented Aggregated Tubular-like
wt/GAL1-FZO1
 Glucose 92 71
 Rafﬁ  nose 90 82
 Galactose 16 79 5
∆mdm30/GAL1-FZO1
 Glucose 89 56
 Rafﬁ  nose 8 6 86
 Galactose 10 86 4
Wild-type (wt) and ∆mdm30 strains expressing mtGFP and harboring a chromo-
somal integration of the GAL1 promoter upstream of the FZO1 coding region 
were grown on glucose, rafﬁ  nose, or galactose, and mitochondrial morphology 
of  100 cells was classiﬁ  ed as fragmented, aggregated, or tubular. Bold num-
bers indicate the most represented class on each condition tested. Notably, mi-
tochondrial tubules observed in ∆mdm30 cells were usually shorter and clearly 
distinct from the tubular morphology of wild-type cells.JCB • VOLUME 173 • NUMBER 5 • 2006  650
To increase the efﬁ  ciency of the α-factor arrest, BAR1 was deleted by PCR-
based homologous recombination in wild-type, cim5-1, and pre1-1 cells.
Plasmids
FZO1,  MDM30, and mdm30 mutant variants (F-box*, with the L19P, 
P20A, E22Q, and I23A mutations; ∆F-box, without the residues 1–58) 
  encoding an NH2-terminal FLAG tag were cloned into the multicopy vector 
pJDCEX2 (2μ; LEU2 and CUP1 promoter). Fzo1 harboring an NH2-  terminal 
HA tag was expressed under the control of the endogenous promoter using 
the centromeric plasmid pRS315 or the multicopy plasmid YEplac181. For 
visualizing mitochondria, the plasmid pVT100U-mtGFP (mitochondria-
  targeted GFP) was used.
Protein synthesis shut off and 𝗂-factor cell cycle arrest
To monitor constitutive proteolysis of Fzo1, cycloheximide was added to 
logarithmically growing yeast cultures at a ﬁ  nal concentration of 100 μg/ml. 
Thermosensitive strains were incubated for 1 h at 37°C before adding 
  cycloheximide. To examine Fzo1 degradation upon α-factor–induced cell 
cycle arrest, early log phase cells grown on YPD were treated with 20 mM 
sodium citrate and 10 μM α-factor (or 0.1 μM in ∆bar1 strains). At the in-
dicated time points, cells corresponding to 3 OD units were collected and 
lysed at alkaline pH (Tatsuta and Langer, 2006), and protein extracts were 
analyzed by SDS-PAGE and immunoblotting. Mean values of at least three 
independent experiments are shown.
Coimmunoprecipitation of Fzo1 and Mdm30
Wild-type cells expressing Mdm30 and variants thereof from a copper-
  responsive promoter were grown on synthetic media without an additional 
copper supplement. Crude mitochondria obtained from 60 OD units of 
these cells were solubilized for 15 min in 1% (wt/vol) digitonin in immuno-
precipitation buffer (150 mM KAc, 4 mM MgAc, 30 mM Tris/HCl, pH 7.4, 
1 mM PMSF, and 1 mM ATP). After a clarifying spin for 15 min at 45,000 g, 
supernatants were incubated for 1 h at 4°C under constant mixing with 
protein A–Sepharose and polyclonal antibodies against the GTPase do-
main of Fzo1. After two washing steps in immunoprecipitation buffer and 
one washing step in 10 mM Tris/HCl, pH 7.4, bound material was eluted 
with SDS sample buffer and used for Western blot analysis.
Antibodies
Antisera against the COOH terminus of Fzo1 (Rapaport et al., 1998), the 
GTPase domain of Fzo1 (provided by J. Nunnari, University of California, 
Davis, Davis, CA), the HA epitope (3F10; Roche), the FLAG epitope 
(M2-F3165; Sigma-Aldrich), or the myc epitope (9B11; Cell Signaling 
Technology) were used.
Microscopy
Overnight cultures were analyzed by epiﬂ  uorescence microscopy on a mi-
croscope (Axioplan; Carl Zeiss MicroImaging, Inc.) using a 100× oil-
  immersion objective. GFP ﬂ  uorescence was visualized in living cells. Images 
were acquired with a camera (Quantix; Photometrix) and processed with 
MetaMorph 4.5 software (Universal Imaging Corp.).
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